Trials / Completed
CompletedNCT00751777
Traveler's Diarrhea (TD) Automated Process
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Immunogenicity and Safety of a Two Vaccination Regimen With an LT Vaccine Patch in Healthy Adults
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Intercell USA, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
To evaluate and compare the immune responses and safety following a two vaccination regimen by transcutaneous immunization with heat-labile enterotoxin of E. coli (LT) patches or placebo patches.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | heat-labile enterotoxin of E. coli (LT) | Travelers' Diarrhea Vaccine System |
| BIOLOGICAL | Placebo | Travelers' Diarrhea Vaccine System |
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2009-11-01
- Completion
- 2009-11-01
- First posted
- 2008-09-12
- Last updated
- 2020-01-29
- Results posted
- 2014-04-21
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00751777. Inclusion in this directory is not an endorsement.